Share of Zydus Lifesciences Limited is currently trading at around Rs.1120/-. Existing as well as Prospective Investors are asking for Zydus Lifesciences Share Price Target 2024,2025,2030,2035 & 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Zydus Lifesciences Share Price Target 2025,2030,2035 & 2040.
Discussion & Analysis of Business & Financial performance with future business prospects of Zydus Lifesciences Ltd:
Zydus Lifesciences Ltd, formerly known as Cadila Healthcare, is one of India’s leading pharmaceutical companies with a strong presence in both domestic and international markets. The company operates across multiple therapeutic areas, including cardiovascular, oncology, gastroenterology, and vaccines, with a diverse portfolio of over-the-counter (OTC) and prescription drugs.
Current Business Performance:
Zydus Lifesciences has experienced a solid growth trajectory, supported by a balanced revenue mix from its India business and global operations, particularly the US market. In FY 2023, the company posted robust financials with revenue growth driven by the performance of key brands like Zyrop (an oncology product) and Pentasa (gastroenterology). Its domestic business contributes significantly, accounting for around 45% of revenues, with a portfolio of high-margin branded products. On the global front, the US business, a key driver, saw improved margins due to better pricing in certain generic segments.
The company is also expanding in the biosimilars and specialty drugs market, with its saroglitazar (a novel drug for liver diseases) gaining international recognition. Recent approvals for complex generics and increasing market share in the US generic space have bolstered its revenue pipeline.
Future Business Prospects:
The future outlook for Zydus Lifesciences is positive, driven by several strategic initiatives. The company is focusing on expanding its specialty products portfolio, particularly in the areas of oncology and biologics. Zydus also has a strong R&D pipeline, with over 200 ANDA (Abbreviated New Drug Application) filings in the US, along with ongoing development in biosimilars and new chemical entities.
In the Indian market, Zydus is poised to benefit from increasing healthcare spending and the growing demand for lifestyle disease drugs. The company’s emphasis on expanding its global footprint, particularly in emerging markets like Brazil and South Africa, presents further growth opportunities.
Additionally, Zydus is investing in digital health initiatives, enhancing its supply chain efficiencies, and expanding manufacturing capabilities, which are expected to drive future profitability. While competition in the generics space and pricing pressures in the US remain challenges, Zydus Lifesciences’ diversified portfolio, innovation in specialty drugs, and focus on operational efficiency position it well for sustained long-term growth.Top of Form
Bottom of Form
Share Price Targets:
Zydus Lifesciences Share Price Target 2024
Based on the above discussion and analysis, the share price of Zydus Lifesciences is likely to touch the level of around Rs.1225-1250 in 2024
Zydus Lifesciences Share Price Target 2025
Based on the above discussion and analysis, the share price of Zydus Lifesciences is likely to touch the level of around Rs.1350-1400 in 2025
Zydus Lifesciences Share Price Target 2030
Based on the above discussion and analysis, the share price of Zydus Lifesciences is likely to touch the level of around Rs.2150-2200 in 2030
Zydus Lifesciences Price Target 2035
Based on the above discussion and analysis, the share price of Zydus Lifesciences is likely to touch the level of around Rs.3450-3600 in 2035
Zydus Lifesciences Price Target 2040
Based on the above discussion and analysis, the share price of Zydus Lifesciences is likely to touch the level of around Rs.5400-6000 in 2040
Disclaimer: Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.
Read Also:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Also Read :
How to make money from share market? (indiatimes.com)
Visit our Website regularly for more such Educational Research Articles:
MoneyInsight – We Provide Insight to Your Money
